ARCA Biopharma Inc - ESG Rating & Company Profile powered by AI
The ESG rating includes 17 UN Sustainable Development Goals including: 'Quality Education', 'Responsible Production & Consumption' and 'Partnerships for the Goals'. If you are employed by ARCA Biopharma Inc and you wish to licence your ESG rating, please get in touch. The report of ARCA Biopharma Inc uses information from across the internet as well as from available filings by ARCA Biopharma Inc.
ARCA Biopharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.7; made up of an environmental score of 0.0, social score of 2.7 and governance score of 5.3.
2.7
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1393 | Vaccinex Inc | 2.8 | Medium |
| 1393 | YSP Southeast Asia Holding Bhd | 2.8 | Medium |
| 1437 | ARCA Biopharma Inc | 2.7 | Medium |
| 1437 | CanadaBis Capital Inc | 2.7 | Medium |
| 1437 | Cannabics Pharmaceuticals Inc | 2.7 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does ARCA Biopharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes ARCA Biopharma Inc report the average age of the workforce?
Sign up for free to unlockDoes ARCA Biopharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes ARCA Biopharma Inc offer flexible work?
Sign up for free to unlockDoes ARCA Biopharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes ARCA Biopharma Inc conduct supply chain audits?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes ARCA Biopharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose water use targets?
Sign up for free to unlockDoes ARCA Biopharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid ARCA Biopharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes ARCA Biopharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas ARCA Biopharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes ARCA Biopharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes ARCA Biopharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs ARCA Biopharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose its waste policy?
Sign up for free to unlockDoes ARCA Biopharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose energy use targets?
Sign up for free to unlockDoes ARCA Biopharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes ARCA Biopharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for ARCA Biopharma Inc
These potential risks are based on the size, segment and geographies of the company.
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorado Prevention Center, the University of Colorado's Academic Research Organization to develop and commercialize Gencaro. The company was incorporated in 2004 and is headquartered in Westminster, Colorado.